Psychiatry

Medicine & Life Sciences

1. HIV-1 100%
2. Macrophages 61%
3. Attention Deficit Disorder with Hyperactivity 40%
4. Brain 36%
5. HIV 33%
6. Encephalitis 33%
7. Parkinson Disease 30%
8. Dementia 29%
9. Microglia 29%
10. Atomoxetine Hydrochloride 27%
11. Therapeutics 26%
12. Virus Diseases 25%
13. Phagocytes 24%
14. Liver Transplantation 24%
15. Depression 24%
16. Monocytes 22%
17. Pharmaceutical Preparations 20%
18. Nanoparticles 19%
19. Child 18%
20. HIV Infections 16%
21. Pediatrics 16%
22. Viruses 16%
23. Neurodegenerative Diseases 15%
24. Alzheimer Disease 15%
25. Proteomics 14%
26. Cognitive Dysfunction 13%
27. Astrocytes 13%
28. Neuroglia 13%
29. Psychiatry 13%
30. Liver 12%
31. T-Lymphocytes 12%
32. Blood-Brain Barrier 12%
33. Atazanavir Sulfate 12%
34. Placebos 12%
35. Neurocognitive Disorders 11%
36. Magnetic Resonance Imaging 11%
37. Adaptive Immunity 11%
38. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine 11%
39. Safety 10%
40. Neuroaid 10%
41. Infections 10%
42. Ebola Hemorrhagic Fever 9%
43. Population 9%
44. Fluoxetine 9%
45. URMC-099 9%
46. Neuroprotection 9%
47. Health 9%
48. Neurons 9%
49. Wounds and Injuries 8%
50. Animal Models 8%
51. Immunity 8%
52. Proteins 8%
53. AIDS Dementia Complex 8%
54. Pharmacokinetics 8%
55. SCID Mice 7%
56. Innate Immunity 7%
57. Drug Therapy 7%
58. Regulatory T-Lymphocytes 7%
59. Education 7%
60. Central Nervous System 7%
61. Nervous System 7%
62. Colorectal Neoplasms 7%
63. Synucleins 7%
64. Students 7%
65. Cognitive Behavioral Therapy 7%
66. Neoplasms 6%
67. Ritonavir 6%
68. Neurotoxins 6%
69. Dopaminergic Neurons 6%
70. Rodentia 6%
71. Nervous System Diseases 6%
72. North American Indians 6%
73. Allografts 6%
74. Nanomedicine 6%
75. Indinavir 6%
76. Psychopharmacology 6%
77. Amyotrophic Lateral Sclerosis 6%
78. Early Detection of Cancer 6%
79. Inflammation 6%
80. Acute Liver Failure 6%
81. Folic Acid 6%
82. Substantia Nigra 6%
83. 4-phenyl-1,2,3,6-tetrahydropyridine 5%
84. Severe Combined Immunodeficiency 5%
85. Geriatric Assessment 5%
86. Disease Progression 5%
87. Manganese 5%
88. Quality of Life 5%
89. Proteome 5%
90. Lymphocytes 5%
91. mitogen-activated protein kinase kinase kinase 11 5%
92. Geriatrics 5%
93. Cognition 5%
94. Laboratory Automation 5%
95. Major Depressive Disorder 5%
96. Chemokines 5%
97. Psychological Inhibition 5%
98. Oxidative Stress 5%
99. Pharmacology 5%
100. Biomarkers 5%